China Life Insurance (2628.HK) Earnings Analysis

China Life Insurance (2628.HK) next reports earnings on 2026-08-28, consensus EPS 1.57 HKD. It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 8.15.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 2628.HK next report earnings?

Next earnings date2026-08-28
Consensus EPS estimate1.57 HKD
Revenue estimate651.27B

2628.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-270.786 HKDn/an/an/a
2026-03-254.45 HKD4.11 HKD+8.3%Beat
2025-08-270.47 HKD1.6 HKD-70.6%Miss
2024-12-310.09073 HKDn/an/an/a
2024-08-290.67 HKD1.04 HKD-35.6%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

2628.HK valuation and analyst view

Trailing P/E8.15
Trailing EPS5.122 HKD
Price / book1.97
Dividend yield2.05%
Market cap1274.43B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is China Life Insurance (2628.HK)'s next earnings date?

China Life Insurance is next scheduled to report on 2026-08-28, with a consensus EPS estimate of 1.57 HKD and revenue estimate of 651.27B.

Did 2628.HK beat earnings last quarter?

Consensus estimate data was not available for 2628.HK's 2026-04-27 report.

What is 2628.HK's earnings track record?

Over the last 3 reported quarters with consensus data, 2628.HK beat estimates 1 times (33%).

What is 2628.HK's current P/E ratio and EPS?

2628.HK trades at a trailing P/E of 8.15 on trailing EPS of 5.122271360339643 HKD.

What do analysts rate 2628.HK?

2628.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.